Please use this identifier to cite or link to this item: http://buratest.brunel.ac.uk/handle/2438/13216
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBourguignon, J-P-
dc.contributor.authorSlama, R-
dc.contributor.authorBergman, Å-
dc.contributor.authorDemeneix, B-
dc.contributor.authorIvell, R-
dc.contributor.authorKortenkamp, A-
dc.contributor.authorPanzica, G-
dc.contributor.authorTrasande, L-
dc.contributor.authorZoeller, RT-
dc.date.accessioned2016-09-23T12:54:38Z-
dc.date.available2016-06-
dc.date.available2016-09-23T12:54:38Z-
dc.date.issued2016-
dc.identifier.citationThe Lancet Diabetes & Endocrinology, 4(8): pp. 643 - 646, (2016)en_US
dc.identifier.issn2213-8587-
dc.identifier.urihttp://bura.brunel.ac.uk/handle/2438/13216-
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.titleScience-based regulation of endocrine disrupting chemicals in Europe: which approach?en_US
dc.typeArticleen_US
dc.identifier.doihttp://dx.doi.org/10.1016/S2213-8587(16)30121-8-
dc.relation.isPartOfThe Lancet Diabetes & Endocrinology-
pubs.publication-statusPublished-
Appears in Collections:Dept of Life Sciences Research Papers

Files in This Item:
File Description SizeFormat 
Fulltext.pdf202 kBUnknownView/Open


Items in BURA are protected by copyright, with all rights reserved, unless otherwise indicated.